Hyperbilirubin in neonate. Neonatal jaundice, unspecified
Conditions
Interventions
Intervention 1: The intervention groups were put under single phototherapy with plastic cover. Intervention 2: The control group were put under single phototherapy without plastic cover.
Treatment - Devices
The intervention groups were put under single phototherapy with plastic cover
The control group were put under single phototherapy without plastic cover.
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Years to 14 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: neonates who had gestational age of 37 and were more than 2500g with the Bilirubin level between 18 and 21, at the beginning of the phototherapy Exclusion criteria: congenital malformations, hemolysis, increased direct Bilirubin ( >20% of the total Bilirubin), sepsis, age less than 48 hours and more than 2 weeks, at the beginning of phototherapy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum Bilirubin level. Timepoint: Each 12 hours. Method of measurement: Laboratory Bilirubin Assay Kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Body Temperature. Timepoint: each 6 hours. Method of measurement: Thermometer.;Dehydatation. Timepoint: each 6 hours. Method of measurement: physical examination.;Stool consistence. Timepoint: each 6 hours. Method of measurement: inspection. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHoma Babaei, MD
Kermanshah University of Medical Sciences
Outcome results
None listed